MNOV
MediciNova, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.63
+0.62%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 19.75x
- P/S forward
- 128.00x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.15x
- Price / sales
- 87.16x
- Price / cash flow
- -0.04x
Enterprise value
- Enterprise value
- $54.9M
- EV / sales
- 59.68x
- EV / EBITDA
- -5.00x
- EV / EBIT
- -4.64x
- Market cap
- $80.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026